These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 27002801)

  • 21. Precancerous bile duct pathology in end-stage primary sclerosing cholangitis, with and without cholangiocarcinoma.
    Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC
    Am J Surg Pathol; 2010 Jan; 34(1):27-34. PubMed ID: 19898228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical Characteristics, Associated Malignancies and Management of Primary Sclerosing Cholangitis in Inflammatory Bowel Disease Patients: A Multicentre Retrospective Cohort Study.
    Guerra I; Bujanda L; Castro J; Merino O; Tosca J; Camps B; Gutiérrez A; Gordillo Ábalos J; de Castro L; Iborra M; Carbajo AY; Taxonera C; Rodríguez-Lago I; Mesonero F; de Francisco R; Gómez-Gómez GJ; Chaparro M; Tardillo CA; Rivero M; Algaba A; Martín Arranz E; Cañete F; Vicente R; Sicilia B; Antolín B; Prieto V; Márquez L; Benítez JM; Camo P; Piqueras M; Gargallo CJ; Hinojosa E; Huguet JM; Pérez Calle JL; Van Domselaar M; Rodriguez C; Calvet X; Muñoz-Villafranca C; García-Sepulcre MF; Munoz-Garrido P; Fernández-Clotet A; Gómez Irwin L; Hernández S; Guardiola J; Sempere L; González Muñoza C; Hernández V; Beltrán B; Barrio J; Alba C; Moraleja I; López-Sanromán A; Riestra S; Martínez Montiel P; Garre A; Arranz L; García MJ; Martín Arranz MD; Corsino P; Arias L; Fernández-Salazar L; Fernández-Pordomingo A; Andreu M; Iglesias E; Ber Y; Mena R; Arroyo Villarino MT; Mora M; Ruiz L; López-Serrano P; Blazquez I; Villoria A; Fernández M; Bermejo F; Banales JM; Domènech E; Gisbert JP;
    J Crohns Colitis; 2019 Dec; 13(12):1492-1500. PubMed ID: 31063540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors and prognosis for recurrent primary sclerosing cholangitis after liver transplantation: a Nordic Multicentre Study.
    Lindström L; Jørgensen KK; Boberg KM; Castedal M; Rasmussen A; Rostved AA; Isoniemi H; Bottai M; Bergquist A
    Scand J Gastroenterol; 2018 Mar; 53(3):297-304. PubMed ID: 29301479
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatobiliary disease in inflammatory bowel disease.
    Balan V; LaRusso NF
    Gastroenterol Clin North Am; 1995 Sep; 24(3):647-69. PubMed ID: 8809241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Malignancies in Primary Sclerosing Cholangitis--A Continuing Threat.
    Bonato G; Cristoferi L; Strazzabosco M; Fabris L
    Dig Dis; 2015; 33 Suppl 2(Suppl 2):140-8. PubMed ID: 26641079
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cholangiocytes in the pathogenesis of primary sclerosing cholangitis and development of cholangiocarcinoma.
    Chung BK; Karlsen TH; Folseraas T
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1390-1400. PubMed ID: 28844951
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of hepato-pancreato-biliary cancer is increased by primary sclerosing cholangitis in patients with inflammatory bowel disease: A population-based cohort study.
    Yu J; Refsum E; Helsingen LM; Folseraas T; Ploner A; Wieszczy P; Barua I; Jodal HC; Melum E; Løberg M; Blom J; Bretthauer M; Adami HO; Kalager M; Ye W
    United European Gastroenterol J; 2022 Mar; 10(2):212-224. PubMed ID: 35107865
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inflammatory bowel disease in patients with primary sclerosing cholangitis: clinical characterization in liver transplanted and nontransplanted patients.
    Jørgensen KK; Grzyb K; Lundin KE; Clausen OP; Aamodt G; Schrumpf E; Vatn MH; Boberg KM
    Inflamm Bowel Dis; 2012 Mar; 18(3):536-45. PubMed ID: 21456044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors for abnormal liver function tests in patients with ileal pouch-anal anastomosis for underlying inflammatory bowel disease.
    Navaneethan U; Remzi FH; Nutter B; Fazio VW; Shen B
    Am J Gastroenterol; 2009 Oct; 104(10):2467-75. PubMed ID: 19550410
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variations in primary sclerosing cholangitis across the age spectrum.
    Eaton JE; McCauley BM; Atkinson EJ; Juran BD; Schlicht EM; de Andrade M; Lazaridis KN
    J Gastroenterol Hepatol; 2017 Oct; 32(10):1763-1768. PubMed ID: 28245345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inflammatory bowel disease complicated by primary sclerosing cholangitis and cirrhosis: is restorative proctocolectomy safe?
    Lian L; Menon KV; Shen B; Remzi F; Kiran RP
    Dis Colon Rectum; 2012 Jan; 55(1):79-84. PubMed ID: 22156871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Natural History of Established and De Novo Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis.
    Mouchli MA; Singh S; Boardman L; Bruining DH; Lightner AL; Rosen CB; Heimbach JK; Hasan B; Poterucha JJ; Watt KD; Kane SV; Raffals LE; Loftus EV
    Inflamm Bowel Dis; 2018 Apr; 24(5):1074-1081. PubMed ID: 29522202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cholangiocarcinoma is associated with a raised enhanced liver fibrosis score independent of primary sclerosing cholangitis.
    Saffioti F; Roccarina D; Vesterhus M; Hov JR; Rosenberg W; Pinzani M; Pereira SP; Boberg KM; Thorburn D
    Eur J Clin Invest; 2019 May; 49(5):e13088. PubMed ID: 30762236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suspicious brush cytology is an indication for liver transplantation evaluation in primary sclerosing cholangitis.
    Boyd S; Vannas M; Jokelainen K; Isoniemi H; Mäkisalo H; Färkkilä MA; Arola J
    World J Gastroenterol; 2017 Sep; 23(33):6147-6154. PubMed ID: 28970730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prospective surveillance for cholangiocarcinoma in unselected individuals with primary sclerosing cholangitis.
    Villard C; Friis-Liby I; Rorsman F; Said K; Warnqvist A; Cornillet M; Kechagias S; Nyhlin N; Werner M; Janczewska I; Hagström T; Nilsson E; Bergquist A
    J Hepatol; 2023 Mar; 78(3):604-613. PubMed ID: 36410555
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inflammatory Bowel Disease and Primary Sclerosing Cholangitis: A Review of the Phenotype and Associated Specific Features.
    Palmela C; Peerani F; Castaneda D; Torres J; Itzkowitz SH
    Gut Liver; 2018 Jan; 12(1):17-29. PubMed ID: 28376583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening and diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis.
    Jesudian AB; Jacobson IM
    Rev Gastroenterol Disord; 2009; 9(2):E41-7. PubMed ID: 19668124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Detection of Cholangiocarcinoma in Primary Sclerosing Cholangitis Patients: Single Center Experience.
    Kuzu UB; Ödemiş B; Suna N; Yıldız H; Parlak E; Dişibeyaz S; Torun S; Akpınar MY; Coşkun O; Turhan N; Yüksel M; Kayaçetin E
    J Gastrointest Cancer; 2016 Mar; 47(1):8-14. PubMed ID: 26537791
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activity of Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis Predicts Poorer Clinical Outcomes.
    Peverelle M; Paleri S; Hughes J; De Cruz P; Gow PJ
    Inflamm Bowel Dis; 2020 Nov; 26(12):1901-1908. PubMed ID: 31944235
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors associated with major radiological progression of primary sclerosing cholangitis in patients with inflammatory bowel disease.
    Azzam N; AlRuthia Y; Alharbi O; Aljebreen A; Almadi M; Loftus EV
    Hepatol Int; 2020 Dec; 14(6):1114-1124. PubMed ID: 33369708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.